CN104126707A - Atherosclerosis-conditioning tea - Google Patents
Atherosclerosis-conditioning tea Download PDFInfo
- Publication number
- CN104126707A CN104126707A CN201410271630.2A CN201410271630A CN104126707A CN 104126707 A CN104126707 A CN 104126707A CN 201410271630 A CN201410271630 A CN 201410271630A CN 104126707 A CN104126707 A CN 104126707A
- Authority
- CN
- China
- Prior art keywords
- tea
- atherosclerotic
- root
- hawthorn
- buckthorn
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention provides atherosclerosis-conditioning tea. According to physical characteristics of atherosclerotic patients, the product is prepared by adopting a traditional Chinese medicine essence theory for targeted reasonable compatibility of medicine and food dual-purpose Chinese herbal extracts comprising hawthorn, lotus leaf, ginseng, Chinese wolfberry, radix puerariae, cassia seed, sea-buckthorn, red yeast rice, natto, mulberry leaf, poria cocos, black fungus, hibiscus sabdariffa and the like. Through effects of biological active ingredients in the medicine and food dual-purpose Chinese herbal medicines, the tea prepared according to the formula can assist to improve the body immunity, is suitable for the atherosclerotic patients to eat, thereby having the unique advantage integrated with triple efficacies of tea therapy, prevention and conditioning.
Description
Technical field
The invention belongs to integration of drinking and medicinal herbs class formula food technical field, the Traditional Chinese Medicine marrow theory of modern biotechnology achievement in research, modern nutriology theory and " medicine among integration of drinking and medicinal herbs " is combined, is the atherosclerotic tea of a kind of conditioning.
Background technology
Atherosclerotic is common most important a kind of in one group of arteriosclerotic angiosis, be characterized in getting involved arterial disease from inner membrance, generally first have that lipid and compound carbohydrate gather, hemorrhage and thrombosis, proliferation of fibrous tissue and calcinosis, and there is medial a transformation gradually and calcification; pathology is often involved elasticity and large medium muscular artery; once develop into, be enough to obstructing arterial chamber; the tissue that this artery is supplied or organ are by ischemic or necrosis; because the lipid outward appearance of gathering at endarterium is yellow congee sample; be therefore called atherosclerotic
Atherosclerotic is exactly on arterial wall, to have deposited the lipid of one deck as milled congee sample, arterial elasticity is lowered, the pathology that tube chamber narrows down, hypertension is to promote atherosclerotic to occur, the important factor of development, and artery is because of the narrow secondary hypertension that causes due to atherosis, therefore between the two, interact, promote mutually, on very close terms, hypertension promotes atherosclerotic, multiple being born in greatly, medium sized artery, the coronary artery that comprises heart, these fortress passages such as the cerebral artery of head, hypertension causes blood to impact endangium, cause tube wall to thicken, tube chamber attenuates, tube wall inner membrance impaired rear be easily cholesterol, lipidosis, increased the weight of the formation of atherosclerotic plaque, therefore, hypertension is atherosclerotic risk factor, atherosclerotic is arteriosclerotic a kind of, greatly, medium sized artery inner membrance occurs containing cholesterol, the yellow substance of class fat etc., how by fat metabolic disturbance, neural blood vessel functional disturbance causes, often cause thrombosis, blood supply disorder etc., also cry atherosis, not exclusively clear and definite in this sick pathogenic factor, but find by extensive and deep teiology investigation, this disease is multi-pathogenesis disease, its hazards comprise: 1, hypertension, clinical and autopsy data all shows, Artery in Patients with Hypertension is atherosis, and the incidence of disease obviously increases, when this may be due to hypertension, arterial wall bears special high pressure, theca interna and endothelial layer damage, low-density lipoprotein is easy to enter arterial wall, and stimulate smooth muscle cell proliferation, cause atherosclerotic, 2, hyperlipemia, clinical data shows, atherosclerotic is common in hypercholesterolemia, animal used as test gives high cholesterol diet can cause atherosclerotic, in recent years research finds that low-density lipoprotein is relevant with reduction and the atherosclerotic of HDL with increasing of utmost point density lipoprotein, in blood, increasing with atherosclerotic generation of triglycerides also has certain relation, recently research finds that LP(a) (Lp (a)) has a substantial connection with atherosclerotic, 3, smoking, in smoker's blood, carbonyl haemoglobin concentration can reach 10-20%, insufficient oxygenation in arterial wall, subintima aliphatic acid is synthetic to be increased, prostacyclin discharges and reduces, blood platelet is easily in arterial wall adhesion and aggregation, in addition, smoking also can make the former protein content of blood middle-high density lipoprotein reduce, serum cholesterol content increases, so that easily suffer from atherosclerotic.In addition, during smoking, in smog, contained nicotine can directly act on heart and coronary artery causes arteriospasm and myocardial damage, 4, diabetes, glycosuria patient is many with hypertriglyceridemia or hypercholesterolemia, as again with hypertension, the atherosclerotic incidence of disease obviously increases, glycosuria patient also often has blood factor Ⅷ to increase and blood platelet activity strengthens, factor Ⅷ is produced by the cell in arterial wall, the pathology that increases expression inner membrance of this factor, movable the increasing of blood platelet easily gathers it on arterial wall, accelerate atherothrombosis and the obturation that causes arterial lumen, insulin resistance and atheroscleroticly have a substantial connection is thought in research in recent years, Patients with NIDDM often has insulin resistance and the hyperinsulinemia coronary heart disease that occurs together, 5, fat, also be atherosclerotic easy trouble factor, obesity can cause increasing of plasma triglyceride and cholesterol levels, overweight people also often occur together hypertension or diabetes, research in recent years thinks that overweight people often has insulin resistance, thereby the atherosclerotic incidence of disease obviously increases,
" integration of drinking and medicinal herbs " is to one of contribution of mankind's most worthy among Chinese original medical science, this is that Chinese original medical science is selected the topmost standard of food, this standard is to be based upon on the basis of " people-oriented ", the traditional Chinese medical science is always emphasized " medication is not as tea treatment ", tea treat become modern pursue recover one's original simplicity, the optimal selection of health diet, modern nutriology and pharmaceutical research are verified, and in medicine-food two-purpose Chinese herbal medicine, the physiologically active ingredient such as contained active polysaccharide class, saponins, phenols has important regulating action to body physiological function; The food of take is following several large outstanding as medicine has advantages of: one, use for a long time medicine therapy to tend to produce various side effects and dependence, but also may impact the health of human body, and dietotherapy is comparatively safe effectively, toxic and side effect is little; Two, tea treat to be used and to be all food common in our daily life, and cheap, let us just can reach the object of conditioning in daily having a dinner, and this is that expensive medical fee is incomparable; Three, tea thing is that medicine also has advantages of no pain, allows people dispel slight illness in the process of enjoying cuisines, has avoided having an injection, taking medicine, even the hardship of operation;
I am the Chinese medicine perfect adaptation with " new resource food " " integration of drinking and medicinal herbs ", diet and health are organically combined, with conditioning prevention, resist atherosclerotic, the invention belongs to integration of drinking and medicinal herbs and new resources class formula tea technical field, a kind of edible tea of atherosclerotic that is applicable to specifically, inheriting on the theoretical treatment method of traditional Chinese medical science marrow, according to atherosclerotic constitutive character, add hawthorn, lotus leaf, ginseng, matrimony vine, the root of kudzu vine, cassia seed, sea-buckthorn, red yeast rice, natto, mulberry leaf, Poria cocos, black fungus, the extract of the multiple integration of drinking and medicinal herbs food materials such as roselle, play hypotensive, reducing blood lipid, rising serum Vascular Endothelial relaxing factor, superoxide dismutase level, reduces Endothelin, Lipoperoxide thing activity level, antagonism platelet adhesion reaction, assemble and thrombosis, the effect of protection arterial wall and hemangiectasis, also can meet atherosclerotic's nutritional need simultaneously, strengthens immunologic function, and the long-term edible simultaneous phenomenon that can improve atherosclerotic, reaches righting reinforcing, strengthening vital QI to eliminate pathogenic factors, improves symptom, is a kind of malignant tumour and non-therapeutic purposes tea of radiotherapy patient of being suitable for.
goal of the invention
The object of this invention is to provide a kind of succession on the theoretical treatment method of traditional Chinese medical science marrow, adopt the tea of " medicine among integration of drinking and medicinal herbs " compound, there is toxic and side effect little, safe and effective, cheap feature, and the atherosclerotic tea of the acceptable a kind of conditioning of people.
summary of the invention
1, realize that the object of the invention is a kind of to be nursed one's health atherosclerotic tea it comprises following component by weight: hawthorn 1900g-2100g, lotus leaf 1900g-2100g, ginseng 1400g-1600g, matrimony vine 900g-1100, root of kudzu vine 900g-1100g, cassia seed 900g-1100g, sea-buckthorn 900g-1100g, mulberry leaf 900g-1100g, black fungus 900g-1100g, roselle 900g-1100g, Poria cocos 900g-1100g;
Above-mentioned included each component by weight can also be: hawthorn 1900g-2100g, lotus leaf 1900g-2100g, ginseng 1400g-1600g, matrimony vine 900g-1100, root of kudzu vine 900g-1100g, cassia seed 900g-1100g, sea-buckthorn 900g-1100g, mulberry leaf 900g-1100g, black fungus 900g-1100g, roselle 900g-1100g, Poria cocos 900g-1100g.
2, above-mentionedly a kind ofly nurse one's health atherosclerotic tea and also comprise following component by weight: hawthorn 1900g-2100g, lotus leaf 1900g-2100g, ginseng 1400g-1600g, matrimony vine 900g-1100, root of kudzu vine 900g-1100g, cassia seed 900g-1100g, sea-buckthorn 900g-1100g, mulberry leaf 900g-1100g, black fungus 900g-1100g, roselle 900g-1100g.
3, above-mentionedly a kind ofly nurse one's health atherosclerotic tea and also comprise following component by weight: hawthorn 1900g-2100g, lotus leaf 1900g-2100g, ginseng 1400g-1600g, matrimony vine 900g-1100, root of kudzu vine 900g-1100g, sea-buckthorn 900g-1100g, mulberry leaf 900g-1100g, black fungus 900g-1100g, roselle 900g-1100g.
4, above-mentionedly a kind ofly nurse one's health atherosclerotic tea and also comprise following component by weight: hawthorn 1900g-2100g, lotus leaf 1900g-2100g, ginseng 1400g-1600g, matrimony vine 900g-1100, root of kudzu vine 900g-1100g, sea-buckthorn 900g-1100g, mulberry leaf 900g-1100g, black fungus 900g-1100g.
5, above-mentionedly a kind ofly nurse one's health atherosclerotic tea and also comprise following component by weight: hawthorn 1900g-2100g, lotus leaf 1900g-2100g, root of kudzu vine 900g-1100g, sea-buckthorn 900g-1100g, mulberry leaf 900g-1100g, black fungus 900g-1100g.
6, above-mentionedly a kind ofly nurse one's health atherosclerotic tea and also comprise following component by weight: hawthorn 1900g-2100g, lotus leaf 1900g-2100g, root of kudzu vine 900g-1100g, sea-buckthorn 900g-1100g, mulberry leaf 900g-1100g.
In aforesaid formula (through pharmacological evaluation, declare health food, and obtain after strong font size) can also add following component by weight: ginkgo leaf 900g-1100g, pseudo-ginseng 900g-1100g, Radix Astragali 900g-1100g, red sage root 900g-1100g, safflower 700g-900g, Radix Angelicae Sinensis 700g-900g, Ligusticum wallichii 700g-900g, the tuber of dwarf lilyturf 700g-900g, moutan bark 600g-800g, root of bidentate achyranthes 600g-800g.
Preparation method of each formula above: during making first by cleaning such as hawthorn, lotus leaf, ginseng, matrimony vine, the root of kudzu vine, cassia seed, sea-buckthorn, red yeast rice, natto, mulberry leaf, Poria cocos, black fungus, roselles, add cycloheptaamylose immersion post-drying, after the broken machine 40-60 of stainless steel powder order is pulverized again, packing heat-sealing type tea filter paper bag into is convenient to go out to carry directly brew, all operations all carries out in clean dried environment, and solved the common bitter taste of Chinese medicine with microcapsules taste masking technology, and the key technology of the industrialization forming production.
Technological merit of the present invention:
The Traditional Chinese Medicine marrow theory of modern biotechnology achievement in research, modern nutriology theory and " medicine among integration of drinking and medicinal herbs " is combined, developed the atherosclerotic tea of a kind of conditioning; Be characterized as physilogical characteristics, metabolic characteristics and nutritional need for atherosclerotic, in conjunction with the traditional Chinese medical science marrow theory Chinese medical extract of the multiple integration of drinking and medicinal herbs composition such as reasonable compatibility hawthorn, lotus leaf, ginseng, matrimony vine, the root of kudzu vine, cassia seed, sea-buckthorn, red yeast rice, natto, mulberry leaf, Poria cocos, black fungus, roselle targetedly, the function factor having in extract plays a part to regulate and recovers total balance of the body; By the present invention's tea of making of filling a prescription, can effectively supplement atherosclerotic's desired nutritional, improve atherosclerotic's nutrition condition, meanwhile, can strengthen atherosclerotic's resistance.
The specific embodiment
Below by following examples, the invention will be further described, and it will contribute to understand the present invention.
Case study on implementation one
Realize the object of the invention atherosclerotic tea of a kind of conditioning and preparation method and comprise the steps, take raw material: hawthorn 1900g-2100g, lotus leaf 1900g-2100g, ginseng 1400g-1600g, matrimony vine 900g-1100, root of kudzu vine 900g-1100g, cassia seed 900g-1100g, sea-buckthorn 900g-1100g, mulberry leaf 900g-1100g, black fungus 900g-1100g, roselle 900g-1100g, Poria cocos 900g-1100g.
Case study on implementation two
The atherosclerotic tea of a kind of conditioning of the present invention and preparation method also comprise the steps, take raw material: hawthorn 1900g-2100g, lotus leaf 1900g-2100g, ginseng 1400g-1600g, matrimony vine 900g-1100, root of kudzu vine 900g-1100g, cassia seed 900g-1100g, sea-buckthorn 900g-1100g, mulberry leaf 900g-1100g, black fungus 900g-1100g, roselle 900g-1100g.
Case study on implementation three
The atherosclerotic tea of above-mentioned conditioning also comprises following component by weight: hawthorn 1900g-2100g, lotus leaf 1900g-2100g, ginseng 1400g-1600g, matrimony vine 900g-1100, root of kudzu vine 900g-1100g, sea-buckthorn 900g-1100g, mulberry leaf 900g-1100g, black fungus 900g-1100g, roselle 900g-1100g.
Case study on implementation four
Above-mentionedly a kind ofly nurse one's health atherosclerotic tea and also comprise following component by weight: hawthorn 1900g-2100g, lotus leaf 1900g-2100g, ginseng 1400g-1600g, matrimony vine 900g-1100, root of kudzu vine 900g-1100g, sea-buckthorn 900g-1100g, mulberry leaf 900g-1100g, black fungus 900g-1100g.
Case study on implementation five
Above-mentionedly a kind ofly nurse one's health atherosclerotic tea and also comprise following component by weight: hawthorn 1900g-2100g, lotus leaf 1900g-2100g, root of kudzu vine 900g-1100g, sea-buckthorn 900g-1100g, mulberry leaf 900g-1100g, black fungus 900g-1100g.
Case study on implementation six
Above-mentionedly a kind ofly nurse one's health atherosclerotic tea and also comprise following component by weight: hawthorn 1900g-2100g, lotus leaf 1900g-2100g, root of kudzu vine 900g-1100g, sea-buckthorn 900g-1100g, mulberry leaf 900g-1100g.
In aforesaid formula (through pharmacological evaluation, declare health food, and obtain after strong font size) can also add following component by weight: ginkgo leaf 900g-1100g, pseudo-ginseng 900g-1100g, Radix Astragali 900g-1100g, red sage root 900g-1100g, safflower 700g-900g, Radix Angelicae Sinensis 700g-900g, Ligusticum wallichii 700g-900g, the tuber of dwarf lilyturf 700g-900g, moutan bark 600g-800g, root of bidentate achyranthes 600g-800g.
The preparation method of each case study on implementation above: during making first by cleanings such as hawthorn, lotus leaf, ginseng, matrimony vine, the root of kudzu vine, cassia seed, sea-buckthorn, red yeast rice, natto, mulberry leaf, Poria cocos, black fungus, roselles, add cycloheptaamylose to soak post-drying, after the broken machine 40-60 of stainless steel powder order is pulverized again, packing heat-sealing type tea filter paper bag into is convenient to go out to carry directly brew, all operations all carries out in clean dried environment, and solved the common bitter taste of Chinese medicine with microcapsules taste masking technology, and the key technology of the industrialization forming production.
In above-mentioned composition, Main Ingredients and Appearance cassia seed has the effect of the content of substantial reduction in triglycerides, cholesterol, by catharsis, can reduce the absorption of enteron aisle to cholesterol, and the metabolism of energy feedback regulation low-density lipoprotein, and then lipopenicillinase, contribute to free movement of the bowels, and heart, blood vessel and kidney and other organs are had to health-care effect, strengthen its power, thereby reduce the pressure to vascular wall, reach the effect of reducing blood pressure and blood fat; The root of kudzu vine has obvious step-down, reduce vascular resistence, increase the effect of CBF, hawthorn has the effects such as reducing blood lipid, blood pressure, cardiac stimulant, arrhythmia, and meanwhile, hawthorn is also the good medicine of spleen benefiting and stimulating the appetite, relieving dyspepsia, phlegm reduction of blood circulation promoting, lotus leaf has the effect of the relieving summer-heat that clears away heart-fire, loose stasis of blood hemostasis, the wind clearing damp that disappears, roselle has reducing fever and causing diuresis, promotes the production of body fluid to quench thirst, regulating the flow of vital energy helps digestion, can be cool, thirst-quenching, eliminate tired, adjusting and balancing blood fat, hypotensive effect.
Claims (7)
1. the atherosclerotic tea of conditioning, is characterized in that its material composition content comprises following component by weight: hawthorn 1900g-2100g, lotus leaf 1900g-2100g, ginseng 1400g-1600g, matrimony vine 900g-1100, root of kudzu vine 900g-1100g, cassia seed 900g-1100g, sea-buckthorn 900g-1100g, mulberry leaf 900g-1100g, black fungus 900g-1100g, roselle 900g-1100g, Poria cocos 900g-1100g.
2. the atherosclerotic tea of conditioning according to claim 1, characterized by further comprising following component by weight: hawthorn 1900g-2100g, lotus leaf 1900g-2100g, ginseng 1400g-1600g, matrimony vine 900g-1100, root of kudzu vine 900g-1100g, cassia seed 900g-1100g, sea-buckthorn 900g-1100g, mulberry leaf 900g-1100g, black fungus 900g-1100g, roselle 900g-1100g.
3. the atherosclerotic tea of conditioning according to claim 1, characterized by further comprising following component by weight: hawthorn 1900g-2100g, lotus leaf 1900g-2100g, ginseng 1400g-1600g, matrimony vine 900g-1100, root of kudzu vine 900g-1100g, sea-buckthorn 900g-1100g, mulberry leaf 900g-1100g, black fungus 900g-1100g, roselle 900g-1100g.
4. the atherosclerotic tea of conditioning according to claim 1, characterized by further comprising following component by weight: hawthorn 1900g-2100g, lotus leaf 1900g-2100g, ginseng 1400g-1600g, matrimony vine 900g-1100, root of kudzu vine 900g-1100g, sea-buckthorn 900g-1100g, mulberry leaf 900g-1100g, black fungus 900g-1100g.
5. the atherosclerotic tea of conditioning according to claim 1, characterized by further comprising following component by weight: hawthorn 1900g-2100g, lotus leaf 1900g-2100g, root of kudzu vine 900g-1100g, sea-buckthorn 900g-1100g, mulberry leaf 900g-1100g, black fungus 900g-1100g.
6. the atherosclerotic tea of conditioning according to claim 1, characterized by further comprising following component by weight: hawthorn 1900g-2100g, lotus leaf 1900g-2100g, root of kudzu vine 900g-1100g, sea-buckthorn 900g-1100g, mulberry leaf 900g-1100g, in aforesaid formula (through pharmacological evaluation, declare health food, and obtain after strong font size) can also add following component by weight: ginkgo leaf 900g-1100g, pseudo-ginseng 900g-1100g, Radix Astragali 900g-1100g, red sage root 900g-1100g, safflower 700g-900g, Radix Angelicae Sinensis 700g-900g, Ligusticum wallichii 700g-900g, the tuber of dwarf lilyturf 700g-900g, moutan bark 600g-800g, root of bidentate achyranthes 600g-800g.
7. the preparation method of the atherosclerotic tea of conditioning according to claim 1, it is characterized in that it comprises the following steps: during making first by hawthorn, lotus leaf, ginseng, matrimony vine, the root of kudzu vine, cassia seed, sea-buckthorn, red yeast rice, natto, mulberry leaf, Poria cocos, black fungus, the cleanings such as roselle, add cycloheptaamylose to soak post-drying, after the broken machine 40-60 of stainless steel powder order is pulverized again, packing heat-sealing type tea filter paper bag into is convenient to go out to carry directly brew, all operations all carries out in clean dried environment, and solved the common bitter taste of Chinese medicine with microcapsules taste masking technology, and the key technology of the industrialization forming production.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410271630.2A CN104126707A (en) | 2014-06-18 | 2014-06-18 | Atherosclerosis-conditioning tea |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410271630.2A CN104126707A (en) | 2014-06-18 | 2014-06-18 | Atherosclerosis-conditioning tea |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104126707A true CN104126707A (en) | 2014-11-05 |
Family
ID=51799758
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410271630.2A Pending CN104126707A (en) | 2014-06-18 | 2014-06-18 | Atherosclerosis-conditioning tea |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104126707A (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104799286A (en) * | 2015-04-30 | 2015-07-29 | 南京中生生物科技有限公司 | Composition for improving immunity and preparation method of composition |
| CN104957293A (en) * | 2015-07-20 | 2015-10-07 | 宁德市安记茶业有限公司 | Processing method of green tea |
| CN106665989A (en) * | 2016-12-19 | 2017-05-17 | 黄腾庆 | Yam puerarin tea and preparation method thereof |
| CN108669266A (en) * | 2018-05-03 | 2018-10-19 | 中南大学湘雅二医院 | A kind of Guava Leaf health protection tea and preparation method thereof |
| CN111888392A (en) * | 2020-08-27 | 2020-11-06 | 御元堂药业股份有限公司 | A Chinese medicinal composition for treating coronary heart disease, cerebral infarction and arteriosclerosis, and preventing apoplexy |
| CN113057328A (en) * | 2021-04-02 | 2021-07-02 | 上海菁睿健康管理有限公司 | Health-care product composition for regulating lipid and preventing and treating carotid plaque as well as preparation method and application thereof |
-
2014
- 2014-06-18 CN CN201410271630.2A patent/CN104126707A/en active Pending
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104799286A (en) * | 2015-04-30 | 2015-07-29 | 南京中生生物科技有限公司 | Composition for improving immunity and preparation method of composition |
| CN104957293A (en) * | 2015-07-20 | 2015-10-07 | 宁德市安记茶业有限公司 | Processing method of green tea |
| CN106665989A (en) * | 2016-12-19 | 2017-05-17 | 黄腾庆 | Yam puerarin tea and preparation method thereof |
| CN108669266A (en) * | 2018-05-03 | 2018-10-19 | 中南大学湘雅二医院 | A kind of Guava Leaf health protection tea and preparation method thereof |
| CN111888392A (en) * | 2020-08-27 | 2020-11-06 | 御元堂药业股份有限公司 | A Chinese medicinal composition for treating coronary heart disease, cerebral infarction and arteriosclerosis, and preventing apoplexy |
| CN113057328A (en) * | 2021-04-02 | 2021-07-02 | 上海菁睿健康管理有限公司 | Health-care product composition for regulating lipid and preventing and treating carotid plaque as well as preparation method and application thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103053748B (en) | Kudzu vine root fat-reducing sugar-reducing health-care tea and preparation method thereof | |
| CN102988638B (en) | Cyclocarya paliurus blood-lipid and blood-sugar reducing health-care tea and preparation method thereof | |
| CN104126707A (en) | Atherosclerosis-conditioning tea | |
| CN107929420A (en) | Improve energy and blood of human body function and improve the Chinese medicine composition and detection method of immunity | |
| CN104208302A (en) | Fructus rosae laevigatae healthy oral solution for reducing blood fat and preparation method thereof | |
| CN104095115A (en) | Hyperglycemia-hyperlipidemia-hypertension relieving and yang strengthening tea | |
| CN103960409A (en) | Blood glucose reduction tea | |
| CN104095103A (en) | Tea for reducing blood lipid | |
| CN108524814A (en) | A kind of Chinese medicine composition and preparation method thereof for reducing blood glucose | |
| CN104082672A (en) | Health-preserving porridge with efficacy of reducing blood sugar level and production method of porridge | |
| CN101467673A (en) | Compound ginseng health product and preparation method thereof | |
| CN104172168A (en) | Convenient food capable of alleviating atherosclerosis | |
| CN103977390B (en) | A kind of preparation method and its usage of ginger onion medicated wine composition | |
| CN104474251B (en) | Composition and its preparation and the application of function are consolidated with brain tonic | |
| CN101279034B (en) | Combined Chinese medicament for curing diabetic with combined internal and external therapies and preparation thereof | |
| CN103283893B (en) | Luocheng gross grape seed rich tea and preparation method thereof | |
| CN105582124A (en) | Traditional Chinese medicine for treating constipation and preparation method of traditional Chinese medicine | |
| CN104126706A (en) | Arrhythmia-conditioning tea | |
| CN104126791A (en) | Micro-ecological special dietary for atherosclerotic patients to eat | |
| CN105055967B (en) | A kind of complex health care product and preparation method with auxiliary hyperglycemic function | |
| CN103725587A (en) | Sealwort and hawthorn vinegar and production method thereof | |
| CN104082670B (en) | A kind of health-preserving porridge with blood pressure reduction effect and preparation method thereof | |
| CN103798472B (en) | A kind of health protection tea and health care's preparation | |
| CN105311470A (en) | Application of pharmaceutical composition containing folium artemisiae argyi in preparing medicine for treating diabetic nephropathy | |
| CN102988747B (en) | Aristida triseta electuary for reducing hypertension, hyperglycemia and hyperlipidemia and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20141105 |